Key Tigecycline Drug Interactions
Tigecycline, a glycylcycline antibiotic used for complicated skin infections, intra-abdominal infections, and multidrug-resistant bugs like Acinetobacter, interacts mainly through CYP3A4 induction and chelation effects. It lowers levels of drugs metabolized by CYP3A4 and binds divalent/trivalent cations, reducing absorption.[1]
Strongest interactions reduce efficacy:
- Warfarin: Tigecycline induces CYP3A4 and CYP2C9, dropping INR by 20-40% within days. Monitor INR daily and adjust doses.[2]
- Oral contraceptives: Decreased ethinyl estradiol exposure by up to 55%; use backup non-hormonal methods.[1]
- Cyclosporine: Levels fall 40%; monitor troughs and increase doses as needed.[3]
How Interactions Impact Treatment Outcomes
These reduce tigecycline's or co-drugs' effectiveness, risking treatment failure in severe infections. For example, in ICU patients on warfarin for sepsis prophylaxis, subtherapeutic INR prolongs hospital stays. Chelation with antacids, dairy, or iron supplements cuts tigecycline bioavailability by 30-50% if taken within 2 hours—administer 2-4 hours apart.[1][4] No major QT prolongation or serotonin risks, unlike some antibiotics.
Common Co-Medications and Adjustments
| Medication Class | Interaction Effect | Management |
|------------------|--------------------|------------|
| Multivalent cations (Mg, Al, Ca, Fe, Zn IV) | Reduced tigecycline AUC by 40-80% | Separate by 3 hours; avoid concurrent infusion [1] |
| CYP3A4 substrates (e.g., tacrolimus, sirolimus) | 20-30% level drop | Therapeutic drug monitoring; dose up [3] |
| Prothrombin time influencers (e.g., digoxin) | Modest PT/INR changes | Frequent labs [2] |
| Retinoids (e.g., isotretinoin) | Potential pseudotumor cerebri | Avoid combination [4] |
No significant interactions with probenecid, unlike tetracyclines.[1]
Who Faces Highest Risks
Critically ill patients on polypharmacy—sepsis cases with mechanical ventilation often get IV tigecycline plus vancomycin or antifungals. Hepatic impairment worsens CYP induction effects; dose-adjust tigecycline (50 mg q12h maintenance after 100 mg load).[4] Pregnancy category D; limited data on neonatal interactions.
Monitoring and Alternatives
Check drug levels, INR, and infection markers weekly. Switch to IV ertapenem or meropenem if cation-heavy regimens needed. Tigecycline patents expired in 2021 (US 6,706,752); generics available, no new interaction data from biosimilars.[5]
Sources
[1] Tigecycline Prescribing Information (Pfizer)
[2] FDA Drug Interactions Table
[3] Clinical Pharmacology Review
[4] Lexicomp Drug Interactions
[5] DrugPatentWatch.com - Tigecycline Patents